This federal contract award is for the delivery of DUPIXENT 200 MG/1.14 ML PEN 1.14ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $8,974.55, is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through March 5, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $11,308.74, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of December 6, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement,...
This federal contract award is for the procurement of DUPIXENT 300 MG/2 ML PEN 2ML medical products, valued at $18,273.09. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). This is a delivery order contract with a firm fixed price pricing type, with a completion date of December 27, 2024. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a...
The federal contract award is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The fixed-price delivery order has a ceiling value of $20,513.52 and a completion date of January 8, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $61,796.23 and an ultimate completion date of February 29, 2024. The contract is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a prescription medication, to the Defense Logistics Agency (DLA). The $33,100.96 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 27, 2024, with a completion date of June 28, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $39,805.07 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 25, 2024. The contract is not designated as a...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $17,697.50 and a completion date of December 17, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of Amerisourcebergen's broader $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,742.69 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 16, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $10,284.44 firm fixed-price delivery order has a completion date of February 11, 2025. The contract is not set-aside and represents part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for the company...